ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

MGNX MacroGenics Inc

4.01
-0.11 (-2.67%)
Last Updated: 17:50:34
Delayed by 15 minutes
Share Name Share Symbol Market Type
MacroGenics Inc NASDAQ:MGNX NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.11 -2.67% 4.01 4.01 4.02 4.135 4.01 4.13 647,372 17:50:34

MacroGenics to Participate in Upcoming Investor Conferences

13/05/2024 12:30pm

GlobeNewswire Inc.


MacroGenics (NASDAQ:MGNX)
Historical Stock Chart


From Apr 2024 to Jun 2024

Click Here for more MacroGenics Charts.

 MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announced that the Company's management will participate in the following investor conferences this month:

    • The Citizens JMP Life Sciences Conference (New York). MacroGenics’ President & Chief Executive Officer, Scott Koenig, M.D., Ph.D., will participate in a fireside chat on Tuesday, May 14, 2024, at 10:30 am ET.  MacroGenics’ management will also participate in one-on-one meetings.
    • TD Cowen’s 5th Annual Oncology Innovation Summit: Insights for ASCO & EHA (Virtual). MacroGenics’ President & Chief Executive Officer, Scott Koenig, M.D., Ph.D., will participate in a fireside chat on Wednesday, May 29, 2024, at 12:30 pm ET.

Webcasts of the above presentations may be accessed under "Events & Presentations" in the Investor Relations section of MacroGenics' website at http://ir.macrogenics.com/events.cfm.  The Company will maintain archived replays of these webcasts on its website for 30 days.

About MacroGenics, Inc.

MacroGenics (the Company) is a biopharmaceutical company focused on developing, manufacturing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer. The Company generates its pipeline of product candidates primarily from its proprietary suite of next-generation antibody-based technology platforms, which have applicability across broad therapeutic domains. The combination of MacroGenics' technology platforms and protein engineering expertise has allowed the Company to generate promising product candidates and enter into several strategic collaborations with global pharmaceutical and biotechnology companies. For more information, please see the Company's website at www.macrogenics.com. MacroGenics and the MacroGenics logo are trademarks or registered trademarks of MacroGenics, Inc.

###

CONTACT:
Jim Karrels, Senior Vice President, CFO
1-301-251-5172,  info@macrogenics.com

1 Year MacroGenics Chart

1 Year MacroGenics Chart

1 Month MacroGenics Chart

1 Month MacroGenics Chart

Your Recent History

Delayed Upgrade Clock